Login to Your Account

Allied Minds raises $80M for drug discovery joint venture with BMS

By Nuala Moran
Staff Writer

Tuesday, April 26, 2016

LONDON – The U.S. technology commercialization specialist Allied Minds plc has raised $80 million from U.K. investors to fund drug discovery programs in-licensed through its partnership with Bristol-Myers Squibb Co.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription